Keyphrases
Electronic Nose (E-nose)
100%
Exhaled Breath
100%
Prostate Cancer
100%
Breath Test
100%
Volatile Organic Compounds (VOCs) Sensor
100%
Exhaled Breath Analysis
37%
Confidence Interval
25%
Prostate Cancer Patients
25%
Volatile Organic Compounds
25%
Artificial Neural Network
25%
Negative Biopsy
25%
Prostate Enlargement
25%
Area under the Curve
12%
Clinical Practice
12%
Netherlands
12%
Negative Predictive Value
12%
Patient Characteristics
12%
Maastricht University
12%
Healthy Individuals
12%
Prior Treatment
12%
Statistical Analysis
12%
Small Sample Size
12%
University Medical Centre
12%
Independent Sample T-test
12%
Non-invasive Device
12%
Patient-centered
12%
Measurement Analysis
12%
Prostate Biopsy
12%
Unnecessary Biopsy
12%
Cancer Types
12%
Initial Biopsy
12%
Pre-test Probability
12%
Cross-validation Method
12%
Noninvasive Diagnostic Method
12%
Cancer Control
12%
Prospective pilot Study
12%
Pearson's chi-square Test
12%
Urology
12%
Data Compression
12%
Compound Patterns
12%
Primary Prostate Cancer
12%
Artificial Neural Network Model
12%
Urological Patient
12%
TUCKER
12%
Handheld Electronic Nose
12%
Invasive Examination
12%
Total Prostate-specific Antigen
12%
INIS
testing
100%
cancer
100%
devices
100%
prostate
100%
nose
100%
volatility
100%
breath
100%
organic compounds
100%
patients
66%
biopsy
33%
control
33%
neural networks
20%
algorithms
6%
data
6%
antigens
6%
curves
6%
validation
6%
values
6%
specificity
6%
sensitivity
6%
tools
6%
computer codes
6%
size
6%
netherlands
6%
design
6%
accuracy
6%
probability
6%
diagnostic techniques
6%
universities
6%
data analysis
6%
gold
6%
medical centers
6%
compression
6%
Medicine and Dentistry
Prostate Cancer
100%
Breathing
100%
Volatile Organic Compound
100%
Electronic Nose
100%
Biopsy Technique
36%
Breath Analysis
27%
Prostate Hypertrophy
18%
Sensitivity and Specificity
9%
Malignant Neoplasm
9%
Diagnosis
9%
Student T Test
9%
Outcome Assessment
9%
Outpatient
9%
Patient Characteristics
9%
Cross-Validation
9%
Chi Square Test
9%
Prostate Specific Antigen
9%
Urology
9%
Prostate Biopsy
9%
Urological Cancer
9%